Skip to main content
. Author manuscript; available in PMC: 2014 Nov 18.
Published in final edited form as: Nano Life. 2013 Dec 27;3(4):1343001. doi: 10.1142/S1793984413430010

Figure 4.

Figure 4

Effect of modification and targeting of various drug delivery vehicles for treatment of brain injury. Upper graph shows a significantly decreased infarct volume after treatment with PBCA nanoparticles modified with SOD and a further decrease when these particles were targeted with NR1 antibody on the particle surface. In the lower graph, a similar trend was observed with liposomes (lipo), poly(lactic acid) (PLA) nanoparticles, and PLGA nanoparticles with bulk loaded SOD.102